PRS33 A Cost-Effectiveness Analysis of Varenicline Versus Buproprion and Nicotine Replacement Therapy in Greece
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.1420
https://www.valueinhealthjournal.com/article/S1098-3015(11)02982-2/fulltext
Section Title :
Respiratory-Related Disorders
Section Order :
1373
First Page :
A493
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02982-2&doi=10.1016/j.jval.2011.08.1420